Vik Chopra
Stock Analyst at Wells Fargo
(1.75)
# 3,151
Out of 4,868 analysts
41
Total ratings
29.41%
Success rate
-3.01%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Overweight | $205 → $190 | $162.77 | +16.73% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $11.91 | +9.15% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $71.13 | +5.44% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $52.08 | +9.45% | 4 | May 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $255 → $246 | $180.01 | +36.66% | 2 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $72.63 | +3.26% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $15.40 | +23.38% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $57.37 | +62.11% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $18.61 | +12.84% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $10.60 | +22.64% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $10.89 | +74.47% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $30.66 | +157.66% | 3 | Feb 23, 2024 |
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $162.77
Upside: +16.73%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $11.91
Upside: +9.15%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $71.13
Upside: +5.44%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $52.08
Upside: +9.45%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255 → $246
Current: $180.01
Upside: +36.66%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $72.63
Upside: +3.26%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $15.40
Upside: +23.38%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $57.37
Upside: +62.11%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $18.61
Upside: +12.84%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $10.60
Upside: +22.64%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $10.89
Upside: +74.47%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $30.66
Upside: +157.66%